0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cytek Biosciences Inc - Trending symbols

Latest News of Cytek Biosciences Inc

DateTitleRead
2025-11-06
23:00
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the YearRead
2025-11-06
22:05
Cytek Biosciences to Participate in Upcoming Investor ConferencesRead
2025-11-06
02:04
Cytek (CTKB) Q3 2025 Earnings Call TranscriptRead
2025-10-29
22:00
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow CytometryRead
2025-10-15
23:00
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive GrowthRead

Notifications

TypeNotificationDate
Bearish Reversal DivergenceMACD Bearish Reversal Divergence2025-11-07



Trends

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Operating Income -137-10,597-10,7342,207-8,5274,279-4,2487,2342,986
EBIT -6,1496,012-137-8,415-8,5521,500-7,0527,326274
Accumulated Other Comprehensive Income -1,579304-1,275-279-1,5541,359-195296101
Total Other Income Expense Net -873-73-946299-647-2-6491,8261,177
Net Interest Income -429-45-474-98-572316-2561,191935
Income before Tax 1523,1153,267-1,1922,075-1,631444-3,747-3,303
EBITDA 6943,2073,901-1,1962,705-1,769936-2,042-1,106
Tax Provision 5054759758655-452203-1,348-1,145
Income Tax Expense 50547597586559541,609-2,754-1,145
Net Income from Continuing Operations 1022,5682,670-1,0751,595-1,344251-2,409-2,158
Net Income Applicable to Common Shares 4922,1782,670-2,178492-44052-2,073-2,021
Net Income 5,599-5,4971022,5682,670-1,2501,420-2,585-1,165
Gross Profit 19,449-4,96314,4865,25919,7451,53221,277-62,425-41,148
Total Revenue 30,619-6,34724,2726,13630,4083,96834,376-60,266-25,890

Comments

How you think about this?

Leave a comment

Stay informed about Cytek Biosciences Inc.

Receive notifications about Cytek Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.